An HIV type 1 subtype B founder effect in Korea: gp160 signature patterns infer circulation of CTL-escape strains at the population level

AIDS Research and Human Retroviruses

Volumn 19, Issue 8, 2003, Pages 631-641

  Daniels, Rod S ^a   Kang, Chun ^b   Patel, Dina ^a   Xiang, Zheng ^a   Douglas, Nigel W ^a   Zheng, Natalie N ^a   Cho, Hae Wol ^b   Lee, Joo Shil ^b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b Korea National Institute of Health   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA; EPITOPE; GLYCOPROTEIN GP 160; HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PROTEASOME;

ADULT; AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENVELOPE GENE; GENE IDENTIFICATION; GENE MAPPING; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; KOREA; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MONOPHYLY; PHYLOGENY; PRIORITY JOURNAL; VIRUS GENE; VIRUS STRAIN;

DATABASES, FACTUAL; EPITOPES, T-LYMPHOCYTE; FOUNDER EFFECT; GENE PRODUCTS, ENV; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP160; HIV INFECTIONS; HIV-1; HUMANS; KOREA; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0042825522     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203322280847     Document Type: Article

References (66)

1. Anonymous: HIV/AIDS status and trends in Korea. Commun Dis Month Pep 2001;12:4-16.
2. de Souza M, Song MS, Carr JK, Sanders-Buell E, Shin Y, Artenstein AW, Lee H, McCutchan FE, and Brown AE: HIV-1 subtypes A and B isolated from the Republic of Korea. AIDS 1997;11:389-391.
3. Oh MD and Choe K: Epidemiology of HIV infection in the Republic of Korea. J Korean Med Sci 1999;14:469-474.
4. Lee JS, Nam JG, Kim EY, Kang C, Koo BK, and Cho HW: Introduction of HIV type 1 subtype E virus into South Korea. AIDS Res Hum Retroviruses 2000;16:1083-1087.
5. Gao F, Vidal N, Li Y, Trask SA, Chen Y, Kostrikis LG, Ho DD, Kim J, Oh MD, Choe K, Salminen M, Robertson DL, Shaw GM, Hahn BH, and Peeters M: Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation. AIDS Res Hum Retroviruses 2001;17:675-688.
6. Kang MR, Cho YK, Chun J, Kim YB, Lee I, Lee HJ, Kim SH, Kim YK, Yoon K, Yang JM, Kim JM, Shin YO. Kang C, Lee JS, Choi KW, Kim DG, Fitch WM, and Kim S: Phylogenetic analysis of the nef gene reveals a distinctive monophyletic clade in Korean HIV-1 cases. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:58-68.
7. Kim EY, Cho YS, Maeng SH, Kang C, Nam JG, and Lee JS: Characterization of V3 loop sequences from HIV type 1 subtype B in South Korea: Predominance of the GPGS motif. AIDS Res Hum Retroviruses 1999;15:681-686.
8. Moore CB, John M, James IR, Christiansen FT, Witt CS, and Mallal SA: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002;296:1439-1443.
9. Anonymous: 1993 revised classification system for HIV infection and expanded case definition for AIDS among adolescents and adults. MMWR 1992;44:1-19.
10. Pyo CW, Choi HB, Han H, Hong YS, and Kim TG: Identification of HLA-A*11 variant (A*1107) in the Korean population. Tissue Antigens 2001;58:190-192.
11. Douglas NW, Knight AI, Hayhurst A, Barrett WY, Kevany MJ, and Daniels RS: An efficient method for the rescue and analysis of functional HIV-1 env genes: Evidence for recombination in the vicinity of the tat/rev splice site. AIDS 1996;10:39-46.
12. Penny MA, Thomas SJ, Douglas NW, Ranjbar S, Holmes H, and Daniels RS: env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses 1996;12:741-747.
13. Bonfield JK, Smith K, and Staden R: A new DNA sequence assembly program. Nucleic Acids Res 1995;23:4992-4999.
14. Smith SW, Overbeek R, Woese CR, Gilbert W, and Gillevet PM: The genetic data environment - an expandable GUI for multiple sequence analysis. Comput Appl Biosci 1994;10:671-675.
15. Douglas NW, Munro GH, and Daniels RS: HIV/SIV glycoproteins: Structure-function relationships. J Mol Biol 1997;273:122-149.
16. Kesimir C, Nussbaum AK, Schild H, Detours V, and Brunak S: Prediction of proteasome cleavage motifs by neural networks. Protein Eng 2002;15:287-296.
17. Gaschen B, Taylor J, Yusim K, Foley B, Gao F, Lang D, Novitsky V, Haynes B, Hahn BH, Bhattacharya T, and Korber B: Diversity considerations in HIV-1 vaccine selection. Science 2002;296:2354-2360.
18. Pearson WR, Robins G, and Zhang T: Generalized neighbor-joining: More reliable phylogenetic tree reconstruction. Mol Biol Evol 1999;16:806-816.
19. Zheng NN and Daniels RS: Maintenance of glycoprotein-determined phenotype in an HIV type 1 (pNL43) env gene-cassetting system. AIDS Res Hum Retroviruses 2001;17:1501-1506.
20. Cecilia D, KewalRamani VN, O'Leary J, Volsky B, Nyambi P, Burda S, Xu S, Littman DR, and Zolla-Pazner S: Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J Virol 1998;72:6988-6996.
21. Yang Z: PAML: A program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 1997;13:555-556.
22. Wain-Hobson S, Sonigo P, Guyader M, Gazit A, and Henry M: Erratic G → A hypermutation within a complete caprine arthritis-encephalitis virus (CAEV) provirus. Virology 1995;209:297-303.
23. Nei M and Gojobori T: Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 1986;3:418-426.
24. Ganeshan S, Dickover RE, Korber BT, Bryson YJ, and Wolinsky SM: Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J Virol 1997;71:663-677.
25. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, and Hendrickson WA: Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393:648-659.
26. Rizzuto CD, Wyatt R, Hernandez-Ramos N, Sun Y, Kwong PD, Hendrickson WA, and Sodroski J: A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 1998;280:1949-1953.
27. De Jong JJ, De Ronde A, Keulen W, Tersmette M, and Goudsmit J: Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: Analysis by single amino acid substitution. J Virol 1992;66:6777-6780.
28. Pollakis G, Kang S, Kliphuis A, Chalaby MI, Goudsmit J, and Paxton WA: N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J Biol Chem 2001;276:13433-13441.
29. Caffrey DR, O'Neill LA, and Shields DC: A method to predict residues conferring functional differences between related proteins: Application.to MAP kinase pathways. Protein Sci 2000;9:655-670.
30. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, Nelson JA, Gairin JE, Hahn BH, Oldstone MB, and Shaw GM: Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997;3:205-211.
31. Soudeyns H, Paolucci S, Chappey C, Daucher MB, Graziosi C, Vaccarezza M, Cohen OJ, Fauci AS, and Pantaleo G: Selective pressure exerted by immunodominant HIV-1-specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope. Eur J Immunol 1999;29:3629-3635.
32. Wilson CC, Brown RC, Korber BT, Wilkes BM, Ruhl DJ, Sakamoto D, Kunstman K, Luzuriaga K, Hanson IC, Widmayer SM, Wiznia A, Clapp S, Ammann AJ, Koup RA, Wolinsky SM, and Walker BD: Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: The ariel project for the prevention of transmission of HIV from mother to infant. J Virol 1999;73:3975-3985.
33. Foley B, Pan H, Buchbinder S, and Delwart EL: Apparent founder effect during the early years of the San Francisco HIV type 1 epidemic (1978-1979). AIDS Res Hum Retroviruses 2000;16:1463-1469.
34. Cleghorn FR, Jack N, Carr JK, Edwards J, Mahabir B, Sill A, McDanal CB, Connolly SM, Goodman D, Bennetts RQ, O'Brien TR, Weinhold KJ, Bartholomew C, Blattner WA, and Greenberg ML: A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago. Proc Natl Acad Sci USA 2000;97:10532-10537.
35. Shankarappa R, Chatterjee R, Learn GH, Neogi D, Ding M, Roy P, Ghosh A, Kingsley L, Harrison L, Mullins JI, and Gupta P: Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: Identification of features that distinguish subtype c sequences in India from other subtype c sequences. J Virol 2001;75:10479-10487.
36. Gonzalez E, Dhanda R, Bamshad M, Mummidi S, Geevarghese R, Catano G, Anderson SA, Walter EA, Stephan KT, Hammer MF, Mangano A, Sen L, Clark RA, Ahuja SS, Dolan MJ, and Ahuja SK: Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: Impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci USA 2001;98:5199-5204.
37. Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A, Margolick J, Vlahov D, Quinn T, Farzadegan H, and Yu XF: Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proc Natl Acad Sci USA 1998;95:12568-12573.
38. Bagnarelli P, Mazzola F, Menzo S, Montroni M, Butini L, and Clementi M: Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. J Virol 1999;73:3764-3777.
39. Wang B, Spira TJ, Owen S, Lal RB, and Saksena NK: HIV-1 strains from a cohort of American subjects reveal the presence of a V2 region extension unique to slow progressors and non-progressors. AIDS 2000;14:213-223.
40. O'Connor DH and Watkins DI: Houdini's box: Towards an understanding of AIDS virus escape from the cytotoxic T-lymphocyte response. Immunogenetics 1999;50:237-241.
41. McMichael AJ and Rowland-Jones SL: Cellular immune responses to HIV. Nature 2001;410:980-987.
42. Del Val M, Schlicht HJ, Ruppert T, Reddehase MJ, and Koszinowski UH: Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 1991;66:1145-1153.
43. Beekman NJ, van Veelen PA, van Hall T, Neisig A, Sijts A, Camps M, Kloetzel PM, Neefjes JJ, Melief CJ, and Ossendorp F: Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site. J Immunol 2000;164:1898-1905.
44. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, and O'Brien SJ: HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999;283:1748-1752.
45. Hendel H, Caillat-Zucman S, Lebuanec H, Carrington M, O'Brien S, Andrieu JM, Schachter F, Zagury D, Rappaport J, Winkler C, Nelson GW, and Zagury JF: New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 1999;162:6942-6946.
46. Day CL, Shea AK, Altfeld MA, Olson DP, Buchbinder SP. Hecht FM, Rosenberg ES, Walker BD, and Kalams SA: Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles. J Virol 2001;75:6279-6291.
47. Bond KB, Sriwanthana B, Hodge TW, De Groot AS, Mastro TD, Young NL, Promadej N, Altman JD, Limpakarnjanarat K, and McNicholl JM: An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais. AIDS Res Hum Retroviruses 2001;17:703-717.
48. Novitsky V, Flores-Villanueva PO, Chigwedere P, Gaolekwe S, Bussman H, Sebetso G, Marlink R, Yunis EJ, and Essex M: Identification of most frequent HLA class I antigen specificities in Botswana: Relevance for HIV vaccine design. Hum Immunol 2001;62:146-156.
49. Bird TG, Kaul R, Rostron T, Kimani J, Embree J, Dunn PP, Bwayo JJ, Plummet FA, Rowland-Jones SL, and Dong T: HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades. AIDS 2002;16:1899-1904.
50. Tang J, Tang S, Lobashevesky E, Myracle AD, Fideli U, Aldrovandi G, Allen S, Musonda R, and Kaslow RA: Favorable and unfavorable HLA class 1 alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J Virol 2002;76:8276-8284.
51. Kim TG, Han H, Lim BU, Kim W, and Kim SM: Distribution of HLA class I alleles and haplotypes in Korean. J Korean Med Sci 1993;8:180-186.
52. Park MH, Hwang YS, Park KS, Tokunaga K, Akaza T, Juji T, and Kim SI: HLA haplotypes in Koreans based on 107 families. Tissue Antigens 1998;51:347-355.
53. Lee KW, Tang TF, and Yang SY: HLA-A*30 alleles and associated haplotypes in the Korean population. Tissue Antigens 1999;54:198-200.
54. Park MH, Whang DH, Kang SJ, and Han KS: HLA-A*02 allele frequencies and haplotypic associations in Koreans. Tissue Antigens 2000;55:250-256.
55. Lee KW and Cho HC: Serologic heterogeneity of HLA-A24 correlates with allelic types in the Korean population. J Korean Med Sci 2000;15:623-626.
56. Pewe L, Xue S, and Perlman S: Infection with cytotoxic T-lymphocyte escape mutants results in increased mortality and growth retardation in mice infected with a neurotropic coronavirus. J Virol 1998;72:5912-5918.
57. Evans DT, O'Connor DH, Jing P, Dzuris JL, Sidney J, da Silva J, Allen TM, Horton H, Venham JE, Rudersdoff RA, Vogel T, Pauza CD, Bontrop RE, DeMars R, Sette A, Hughes AL, and Watkins DI: Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat Med 1999;5:1270-1276.
58. O'Connor DH, Allen TM, Vogel TU, Jing P, DeSouza IP, Dodds E, Dunphy EJ, Melsaether C, Mothe B, Yamamoto H, Horton H, Wilson N, Hughes AL, and Watkins DI: Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat Med 2002;8:493-499.
59. Kaur A, Alexander L, Staprans SI, Denekamp L, Hale CL, Mc-Clure HM, Feinberg MB, Desrosiers RC, and Johnson RP: Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection. Eur J Immunol 2001;31:3207-3217.
60. Chang KM, Rehermann B, McHutchison JG, Pasquinelli C, Southwood S, Sette A, and Chisari FV: Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C vires. J Clin Invest 1997;100:2376-2385.
61. Burrows JM, Burrows SR, Poulsen LM, Sculley TB, Moss DJ, and Khanna R: Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: Implications for virus evolution. J Virol 1996;70:2490-2496.
62. Shim YS, Kim CW, and Lee WK: Sequence variation of EBNA2 of Epstein-Barr virus isolates from Korea. Mol Cells 1998;8:226-232.
63. McCutchan FE, Artenstein AW, Sanders-Buell E, Salminen MO, Carr JK, Mascola JR, Yu XF, Nelson KE, Khamboonruang C, Schmitt D, Kieny MP, McNeil JG, and Burke DS: Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa. J Virol 1996;70:3331-3338.
64. Kaufman J and Jing J: China and AIDS - the time to act is now. Science 2002;296:2339-2340.
65. Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM, Rosenberg ES, Nguyen T, Allen R, Trocha A, Altfeld M, He S, Bunce M, Funkhouser R, Pelton SI, Burchett SK, McIntosh K, Korber BT, and Walker BD: Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2001;412:334-338.
66. Stein DS, Timpone JG, Gradon JD, Kagan JM, and Schnittman SM: Immune-based therapeutics: Scientific rationale and the promising approaches to the treatment of the human immunodeficiency virus-infected individual. Clin Infect Dis 1993;17:749-771.